Corbion/€CRBN

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Corbion

Corbion NV, trading under the ticker CRBN, is a Netherlands-based company specializing in biochemical ingredients. Operating within the biochemical sector, Corbion offers an extensive range of products including lactic acid and its derivatives, as well as other bio-based chemicals for various industries. Founded in 1919, the company has grown to serve a global market, providing ingredients and solutions for food, biochemical applications, and more.

Ticker

€CRBN
Sector

Primary listing

AEX

Employees

2,403

Corbion Metrics

BasicAdvanced
€976M
14.98
€1.12
1.01
€0.64
3.81%

What the Analysts think about Corbion

Analyst ratings (Buy, Hold, Sell) for Corbion stock.

Bulls say / Bears say

Corbion delivered organic sales growth of 7.9% in Q1 2025, driven by an 8.4% volume/mix increase, reflecting robust demand across its product portfolio (Reuters)
Adjusted EBITDA surged 57.7% to €54.4 million in Q1 2025, with margins expanding to 16.5%, underscoring effective cost management and operational leverage (Reuters)
In FY 2024, Corbion’s Adjusted EBITDA margin improved to 13.6% from 11.1% a year earlier, driven by operational efficiencies and restructuring benefits (Reuters)
Pricing pressure persists, with average selling prices down 0.5% in Q1 2025, indicating limited pricing power that could weigh on future revenue growth (Reuters)
Raw material cost volatility remains a risk, as sugar prices—which account for a significant share of Corbion’s feedstock—could fluctuate and compress margins, despite expectations of lower prices supporting EBITDA in 2026 (Reuters)
Analyst forecasts for only 3–5% annual organic sales growth imply that Corbion’s 2025 volume/mix target of 2–6% may skew toward the low end, highlighting the challenge of achieving its bullish growth outlook in a potentially slowing market (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.

Corbion Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Corbion Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €CRBN

Sign up or log in to buy
Capital at risk
Extended hours trading

Upcoming events

No upcoming events
FAQs
Buy Corbion stock | €CRBN Share Price | Lightyear